(Q34013878)

30 July 2017

1 reference

title

A history of prostate cancer treatment (English)

1 reference

30 July 2017

1 reference

Samuel R Denmeade

1

1 reference

30 July 2017

John T Isaacs

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

30 July 2017

published in

Nature Reviews Cancer

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

389-396

1 reference

Retropubic prostatectomy; a new extravesical technique; report of 20 cases

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

QUANTITATIVE STUDIES OF PROSTATIC SECRETION : II. THE EFFECT OF CASTRATION AND OF ESTROGEN INJECTION ON THE NORMAL AND ON THE HYPERPLASTIC PROSTATE GLANDS OF DOGS.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

The development of androgen-independent prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

28 July 2018

Cancer statistics, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Prostate cancer: a brief history and the discovery of hormonal ablation treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Modern prostate brachytherapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Peptide analogs in the therapy of prostate cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Complete androgen blockade for prostate cancer: what went wrong?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

An address system in the vasculature of normal tissues and tumors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Implication of cell kinetic changes during the progression of human prostatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Enzymatic activation of prodrugs by prostate-specific antigen: targeted therapy for metastatic prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Ketoconazole Blocks Adrenal Steroid Synthesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Radiotherapy in the conservative treatment of operable and locally inoperable carcinoma of the prostate

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Selective Retention of Dihydrotestosterone by Prostatic Nuclei

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urol

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Chemotherapy of Advanced Prostatic Carcinoma with Cyclophosphamide or 5-Fluorouracil: Results of First National Randomized Study

28 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

28 July 2018

https://api.crossref.org/works/10.1038%2FNRC801

Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma

31 March 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Paradoxical Effects of d-Trp6-Luteinizing Hormone-Releasing Hormone on the Hypothalamic-Pituitary-Gonadal Axis in Immature Female Rats

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Pituitary Gonadotropin Inhibition by a Highly Active Analog of Luteinizing Hormone-Releasing Hormone

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Purification of a human prostate specific antigen

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

II. The Present Position of the Surgery of the Hypertrophied Prostate

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4124639

STUDIES ON PROSTATIC CANCER

29 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

PROSTATE CANCER: A BRIEF HISTORY AND THE DISCOVERY OF HORMONAL ABLATION TREATMENT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Hypothalamic Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH)-Regulating Hormone: Structure, Physiology, and Clinical Studies**The work described here has been supported by research grants from the Veterans Administration, United State

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

A soluble androgen receptor in the cytoplasm of rat prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

The Effects of Orchidectomy, Estrogens, and Cyproterone Acetate on Plasma Testosterone, LH, and FSH Concentrations in Patients with Carcinoma of the Prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urolo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Action of a nonsteroidal antiandrogen, flutamide, on the receptor binding and nuclear retention of 5 alpha-dihydrotestosterone in rat ventral prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

RETROPUBIC PROSTATECTOMY A NEW EXTRAVESICAL TECHNIQUE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Ultrasound-guided prostate biopsy. Biopty gun superior to aspiration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

COBALT-60 TELECURIETHERAPY IN THE DEFINITIVE TREATMENT OF CARCINOMA OF THE PROSTATE: A PRELIMINARY REPORT

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

LINEAR ACCELERATOR SUPERVOLTAGE RADIOTHERAPY. VII. CARCINOMA OF THE PROSTATE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

External beam radiation therapy of primary carcinoma of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Systemic treatment for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Chemotherapy Programs of the National Prostatic Cancer Project (NPCP)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Response criteria for the prostate of the USA national prostatic cancer project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC801

The Effect of Castration on Benign Hypertrophy of the Prostate in Man

31 March 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/12044015

12 December 2020

The Intranuclear Binding of Testosterone and 5α-Androstan-17β-ol-3-one by Rat Prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/12044015

12 December 2020

Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12044015

12 December 2020

Chemotherapy programs of the National Prostatic Cancer Project (NPCP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/12044015

12 December 2020

Use of human prostate-specific antigen in monitoring prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12044015

12 December 2020

A prostate antigen in sera of prostatic cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12044015

12 December 2020

Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients. Prostate Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12044015

12 December 2020

Identifiers

DOI

10.1038/NRC801

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference